CAU
PFE icon

Caxton Associates (UK)’s Pfizer PFE Stock Holding History

Caxton Associates (UK)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-102,241
Closed -$2.55M – 952
2025
Q4 		$2.55M Sell
102,241
-13,749
-12% -$347K 0.05% 148
2025
Q3 		$2.96M Sell
115,990
-12,501
-10% -$309K 0.07% 131
2025
Q2 		$3.11M Buy
128,491
+2,797
+2% +$65.2K 0.08% 130
2025
Q1 		$3.19M Buy
+125,694
New +$3.29M 0.11% 80

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Caxton Associates (UK)'s PFE Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Pfizer (PFE) in Q1 2026, closing a stake of 102,241 shares — an estimated $2.55M sold.

Caxton Associates (UK) first reported a position in PFE in Q1 2025 and held it in 4 quarters. The position peaked at $3.19M in Q1 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 102,241 Pfizer shares in Q1 2026, an estimated $2.55M.
  • Caxton Associates (UK) first reported a position in Pfizer in Q1 2025 and held it in 4 quarters.
  • Caxton Associates (UK)'s Pfizer position peaked at $3.19M in Q1 2025.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.